Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels.

MBio
Changze HanHillel Haim

Abstract

HIV-1 group M was transmitted to humans nearly one century ago. The virus has since evolved to form distinct clades, which spread to different regions of the world. The envelope glycoproteins (Envs) of HIV-1 have rapidly diversified in all infected populations. We examined whether key antigenic sites of Env and signatures of vaccine efficacy are evolving toward similar or distinct structural forms in different populations worldwide. Patterns of amino acid variants that emerged at each position of Env were compared between diverse HIV-1 clades and isolates from different geographic regions. Interestingly, at each Env position, the amino acid in the clade ancestral or regional-founder virus was replaced by a unique frequency distribution (FD) of amino acids. FDs are highly conserved in populations from different regions worldwide and in paraphyletic and monophyletic subclade groups. Remarkably, founder effects of Env mutations at the clade and regional levels have gradually decreased during the pandemic by evolution of each site toward the unique combination of variants. Therefore, HIV-1 Env is evolving at a population level toward well-defined "target" states; these states are not specific amino acids but rather specific distrib...Continue Reading

References

Nov 25, 1988·Science·B D PrestonL A Loeb
Jun 12, 1998·Nature Medicine·J N ReitterR C Desrosiers
Nov 21, 2001·British Medical Bulletin·B KorberV Detours
Jun 29, 2002·Science·Brian GaschenBette Korber
Mar 21, 2003·Nature·Xiping WeiGeorge M Shaw
Oct 20, 2006·Trends in Microbiology·Roger D KouyosSebastian Bonhoeffer
Jun 7, 2007·PloS One·David C NickleSergei L Kosakovsky Pond
Apr 12, 2008·The New England Journal of Medicine·Barbara S TaylorScott M Hammer
May 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brandon F KeeleGeorge M Shaw
Mar 31, 2009·AIDS Research and Human Retroviruses·Rebecca M LynchCynthia A Derdeyn
Jun 3, 2009·The Journal of Experimental Medicine·Jesus F Salazar-GonzalezGeorge M Shaw
Jan 6, 2010·Current Opinion in HIV and AIDS·Bette Korber, S Gnanakaran
Aug 31, 2010·Nature Medicine·Evelien M BunnikHanneke Schuitemaker
Oct 22, 2011·PloS One·Chengli ShenPhalguni Gupta
Apr 6, 2012·The New England Journal of Medicine·Barton F HaynesJerome H Kim
May 28, 2013·Nature Structural & Molecular Biology·Leopold KongIan A Wilson
Mar 5, 2014·Nature·Nicole A Doria-RoseJohn R Mascola
Aug 22, 2014·Journal of Virology·Peter HraberDavid C Montefiori
Mar 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Daniel T ClaiborneEric Hunter
Jan 31, 2017·Immunological Reviews·Bette KorberBeatrice H Hahn
Mar 30, 2017·Nature Communications·Liwei CaoJames C Paulson
May 2, 2017·Virus Evolution·Fabio ZaniniRichard A Neher
Oct 13, 2018·Virus Evolution·Eva BonsRoland R Regoes
Jan 11, 2019·Cell Host & Microbe·Christine A BricaultBette Korber

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Software Mentioned

PhyML3
HMMER3

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.